Proof-of-Concept and Safety of the Anti-FcRn Antibody Rozanolixizumab in Patients with Moderate-to-Severe Generalized Myasthenia Gravis (GMG): A Phase 2a StudyVera Bril,Michael Benatar,Melissa Brock,Bernhard Greve,Peter Kiessling,Franz Woltering,Peter Van den BerghNEUROLOGY(2019)引用 25|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要